• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    6/5/25 4:47:57 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    false 0001860543 0001860543 2025-05-30 2025-05-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    Form 8-K

    Current Report 

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 30, 2025

     

    CADRE HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 001-40698 38-3873146
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification Number)

     

    13386 International Pkwy  
    Jacksonville, Florida 32218
    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (904) 741-5400

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol Name of each exchange on which
    registered
    Common Stock, par value $.0001 CDRE New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      x Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    (e)        On May 30, 2025, Cadre Holdings, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the Cadre Holdings, Inc. Employee Stock Purchase Plan (the “Plan”), that, among other things, reserved for issuance under the Plan 1,000,000 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”). The Plan had previously been approved by the Company’s Board of Directors on April 16, 2025, subject to the approval of the Company’s stockholders.

     

    The material terms and conditions of the Plan are described in detail under “PROPOSAL 3 APPROVAL AND ADOPTION OF THE EMPLOYEE STOCK PURCHASE PLAN” of the Company’s Proxy Statement filed by the Company with the Securities and Exchange Commission on April 24, 2025 (the “Proxy Statement”) and are incorporated by reference into Item 5.02 of this Current Report on Form 8-K. A copy of the Plan is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference as if fully set forth herein. The foregoing summary description of the Plan is not intended to be complete and is qualified in its entirety by the complete text of the Plan.

     

    Item 5.07Submission of Matters to a Vote of Security Holders.

     

    (a)       Of the 40,659,585 shares of Common Stock outstanding and entitled to vote at the Annual Meeting, 38,682,080 shares of Common Stock were present in person or by proxy and entitled to vote, representing approximately 95.1% of the shares of Common Stock entitled to vote at the Annual Meeting.

     

    (b)       At the Annual Meeting, the Company’s stockholders: (i) approved the election of each of the following five director nominees standing for election: Warren B. Kanders, Gianmaria C. Delzanno, Hamish Norton, William Quigley and Deborah A. DeCotis, (ii) ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025, and (iii) approved and adopted the Plan.

     

    The voting results for each proposal are set forth below:

     

    Proposal 1 – To elect five members to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified:

     

     

    Name Votes For Votes Withheld

    Broker

    Non-Votes

    Warren B. Kanders 34,573,317 856,715 3,252,048
    Gianmaria C. Delzanno 31,350,919 4,079,113 3,252,048
    William Quigley 34,827,127 602,905 3,252,048
     Hamish Norton 26,717,948 8,712,084 3,252,048
    Deborah A. DeCotis 31,181,980 4,248,052 3,252,048

     

     

     

     

     

    Proposal 2 – To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025:

    Votes For Votes Against Votes Abstained

    Broker

    Non-Votes

    38,564,098 117,055 926  0

     

    Proposal 3 – To approve and adopt the Cadre Holdings, Inc. Employee Stock Purchase Plan.

     

    Votes For Votes Against Votes Abstained

    Broker

    Non-Votes

    35,395,628 23,059 11,344  3,252,048

     

     

    Item 9.01.Financial Statements and Exhibits

     

    (d) Exhibits.

     

    Exhibit

    Description

     

    10.1 Cadre Holdings, Inc. Employee Stock Purchase Plan
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: June 5, 2025 

      CADRE HOLDINGS, INC.
         
         
      By: /s/ Blaine Browers
      Name: Blaine Browers
      Title: Chief Financial Officer

      

     

     

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • Cadre Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      6/5/25 4:47:57 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SD filed by Cadre Holdings Inc.

      SD - Cadre Holdings, Inc. (0001860543) (Filer)

      5/30/25 4:06:20 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form 144 filed by Cadre Holdings Inc.

      144 - Cadre Holdings, Inc. (0001860543) (Subject)

      5/20/25 4:33:38 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CEO AND CHAIRMAN Kanders Warren B sold $4,200,750 worth of shares (125,000 units at $33.61) (SEC Form 4)

      4 - Cadre Holdings, Inc. (0001860543) (Issuer)

      6/5/25 4:15:25 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Decotis Deborah A

      4 - Cadre Holdings, Inc. (0001860543) (Issuer)

      6/3/25 4:49:53 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Delzanno Gianmaria C

      4 - Cadre Holdings, Inc. (0001860543) (Issuer)

      6/3/25 4:48:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care